本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Taysha Gene Therapies, Inc.

5.02
-0.1400-2.71%
盤後5.020.00000.00%19:58 EDT
成交量:177.75萬
成交額:896.70萬
市值:16.36億
市盈率:-12.17
高:5.28
開:5.26
低:4.98
收:5.16
52周最高:7.30
52周最低:2.71
股本:3.26億
流通股本:2.33億
量比:0.85
換手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-0.4126
每股收益(LYR):-0.3409
淨資產收益率:-47.05%
總資產收益率:-23.82%
市淨率:4.22
市盈率(LYR):-14.73

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/19

重要事件披露

Form 8-K - Current report
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities